Involvement of endogenous digitalis-like factors in voluntary selection of alcohol by rats

Life Sciences

Volumn 64, Issue 20, 1999, Pages PL219-PL225

  Bagrov, Yakov Y ^a   Dmitrieva, Natalia I ^a   Manusova, Natalia B ^a   Zvartau, Edwin E ^b   Patkina, Nadezhda A ^b   Bagrov, Alexei Y ^a,c  

^a SIEPB   (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alcohol consumption inhibitor; Bufodienolide; Ethanol; Na K ATPase; Ouabain; Voluntary alcohol consumption

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALCOHOL; DIGITALIS LIKE FACTOR; OUABAIN;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRINKING BEHAVIOR; MALE; NEUROMODULATION; NONHUMAN; RAT;

ANIMALIA; DIGITALIS; LAKE VICTORIA MARBURGVIRUS; RATTUS NORVEGICUS; STROPHANTHUS GRATUS;

EID: 0033537947     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(99)00131-9     Document Type: Article

References (31)

1. A. Goto, K. Yamada, N. Yagi, M. Yoshioka, and T. Sugimoto, Pharmacol. Rev. 44 377-399 (1992).
2. J.M. Hamlyn and P. Manunta, J. Hypertens. 10 S99-S111 (1992).
3. D. Lichtstein and S. Samuelov, Biochem. Biophys. Res. Commun. 96 1518-1523 (1980).
4. N. Zhao, L.C. Lo, N. Berova, K. Nakanishi, A.A. Tymiak, J.H. Ludens and G.T. Haupert Jr., Biochemistry 34 9893-9896 (1995).
5. D. Lichtstein, I. Gati, S. Samuelov, D. Berson, Y. Rosenman, L. Landau and J. Deutsch, Eur. J. Biochem. 216 261-268 (1993).
6. B. Sich, U. Kirch, M. Tepel, W. Zidek and W. Schoner, Hypertension 27 1073-1077 (1996).
7. A.Y. Bagrov, O.V. Fedorova, J.L. Austin, R.I. Dmitrieva and D.E. Anderson, Hypertension 26 781-788 (1995).
8. A.Y. Bagrov, O.V. Fedorova, R.I. Dmitrieva, W.N. Howald, A.P. Hunter, E.A. Kuznetsova and V.M. Shpen, Hypertension 31 1097-1103 (1998).
9. A.Y. Bagrov, R.I. Dmitrieva, O.V. Fedorova, G.P. Kazakov, N.I. Roukoyatkina and V.M. Shpen. Am. J. Hypertens. 9 982-990 (1996).
10. H. Teruya, M. Yamazato, H. Muratani, A. Sakima, S. Takishita, Y. Terano and K. Fukiyama. J. Clin. Invest. 99 2791-2798 (1997).
11. C. De Angelis, and G.T. Haupert Jr, Am. J. Physiol 274 F182-F188 (1998).
12. B.S. Huang, E. Harmsen, H. Yu and F.H. Leenen, Circ. Res. 71 1059-1066 (1992).
13. A. Goto, K. Yamada, H. Nagoshi, Y. Terano and M. Omata, Hypertension 26 1173-1176 (1995).
14. M. Hokin-Neaverson and J.W. Jefferson, Neuropsychobiology 22 1-7 (1989).
15. J.R. Hibbeln, J.W. Palmer and J.M. Davis, Biol Psychiatry 25 945-961 (1989).
16. P.J. Christo AMD R.S. El-Mallakh, Medical Hypotheses 41 378-383 (1993).
17. R. Li, R.S. El-Mallakh, L. Harrison, D.G. Changaris and R.S Levy, Mol. Chem. Neuropathol. 31 65-72 (1997).
18. B. Tabakoff, and P.L Hoffman In: Alcoholism. Biomedical and Genetic Aspects. New York, Oxford: Pergamon Press (1989).
19. B.E. Leonard, Biochem. Pharmacol. 21, 325-338 (1986).
20. D.M. Foster, M.D. Huber, and W.R. Klemm, Alcohol 6 437-443 (1989).
21. T.D. Foley, D.E. Rhoads, Brain Res. 653 PL273-PL278 (1994).
22. T.D. Foley and M. Linnoila, Eur. J. Pharmacol. 292 287-292 (1995).
23. Y.Y. Bagrov, N.I, Dmitrieva, and N.B. Manusova, Proc. Russ. Acad. Sci. 348 268-269 (1996).
24. M.A. Gerrits, N. Patkina, E.E. Zvartau and J.M. Van Ree, Psychopharmacology 119 92-98 (1995).
25. K. Eriksson,. Science 161 76-77 (1968).
26. E. Harlow and D. Lane, Antibodies. Cold Spring Harbor Laboratory. (1988).
27. S. Opava Stitzer and M. Martinez-Maldonado, Clearence methods in the rat. In: Methods in Pharmacology, Vol. 4B, Renal Pharmacology, Plenum, NY-London, (1978).
28. S. Dutta and B.H. Marks, Life Sci. 5 915-920 (1966).
29. T.D. Foley and M. Linnoila, Life Sce. 52 273-278 (1993).
30. O. Fedorova, P. Doris and A. Bagrov, Clin. Exp. Hypertens. 20 581-591 (1998).
31. A. Marcou, T.R. Kosten and G.F. Koob, Neuropsychopharmacology 18 135-174 (1998).